A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
Clinical trial NCT06049082 · RECRUITING
Trial details
- NCT number
- NCT06049082
- Sponsor
- Krystal Biotech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2025-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.